Doctor profile · Federal record
Dr. CHIRAG JHAVERI, M.D.
Ophthalmology Physician (CMS: OPHTHALMOLOGY) · Ophthalmology Physician · Ophthalmology Physician · AUSTIN, TX
- NPI 1114117769
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 20 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3705 MEDICAL PKWY STE 460
AUSTIN, TX 787051024
(512) 454-5851
fax (512) 454-5853
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- June 11, 2020
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (3)
- Texas #P3901 · Illinois #036125974 · Louisiana #MD.201807
- Medicaid
- LA #1005886
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1114117769. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
25,353
Distinct HCPCS
10
Medicare allowed
$1,945,917
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 20,160 | 76 | $37 | |
92134 |
Imaging of retina | 1,362 | 577 | $40 | |
92014 |
Established patient complete exam of visual system | 974 | 519 | $127 | |
92201 |
Extended exam of the back part of the eye with retinal drawing | 955 | 556 | $25 | |
67028 |
Injection of drug into eye | 646 | 188 | $126 | |
J0178 |
Injection, aflibercept, 1 mg | 588 | 94 | $845 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 169 | 94 | $89 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 98 | 98 | $164 | |
J3490 |
Unclassified drugs | 93 | 36 | $3,927 | |
92250 |
Photography of the retina | 86 | 67 | $36 |
In context: peer comparison
Among 40 peers in this city , average services per provider: 423. This provider delivers 60× the peer median.Open Payments
Industry payments received
All-time total
$60,517
Transactions
66
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US Inc | 30 | $42,464.77 | |
| Regeneron Healthcare Solutions, Inc. | 11 | $8,654.74 | |
| Regeneron Pharmaceuticals, Inc. | 3 | $4,499.97 | |
| ABBVIE INC. | 6 | $2,845.23 | |
| Boehringer Ingelheim International GmbH | 4 | $1,585.44 | |
| Ocular Therapeutix, Inc. | 4 | $196.48 | |
| Genentech USA, Inc. | 6 | $132.17 | |
| Alimera Sciences, Inc. | 1 | $125.21 | |
| Apellis Pharmaceuticals, Inc. | 1 | $13.25 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
378
Patients
176
Total drug cost
$14,393
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 112 | 29 | $2,586 |
| Prednisolone Acetate | Generic | 88 | 66 | $6,184 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 65 | 24 | $1,760 |
| Ciprofloxacin Hcl | Generic | 35 | 31 | $464 |
| Brimonidine Tartrate | Generic | 28 | 0 | $728 |
| Difluprednate | Generic | 18 | 11 | $2,156 |
| Ofloxacin | Generic | 16 | 15 | $388 |
| Timolol Maleate | Generic | 16 | 0 | $127 |